Travere Therapeutics

eric dube

Pharma

Travere CEO Eric Dube to step down

Bradley Campbell, who led Amicus Therapeutics until its recent $4.8 billion acquisition by BioMarin, will become Travere's new CEO.

Angus Liu Sep 22, 2026 10:10am

space launch rocketship

Travere’s launchpad positions Filspari for fast rollout: analyst

Apr 24, 2026 10:06am

long road journey highway desert mountains path

Travere charts blockbuster path for Filspari after key approval

Apr 14, 2026 7:05pm

Human kidney anatomy

In another win for rare disease, Travere nabs FDA’s first FSGS nod

Apr 13, 2026 6:25pm

Lifeline

Fierce Biotech

Midsize biotechs form coalition to fight against MFN policy

Feb 25, 2026 1:05pm

delay FDA delay

Travere's bid to gain new approval for Filspari hits FDA hitch

Jan 14, 2026 11:22am